FORA Capital LLC Invests $11.88 Million in Humana Inc. (NYSE:HUM)

FORA Capital LLC bought a new stake in Humana Inc. (NYSE:HUM) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 37,517 shares of the insurance provider’s stock, valued at approximately $11,883,000. Humana comprises approximately 1.4% of FORA Capital LLC’s holdings, making the stock its 6th biggest holding.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Creative Financial Designs Inc. ADV grew its position in shares of Humana by 244.0% in the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock valued at $27,000 after buying an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. boosted its stake in Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after acquiring an additional 39 shares in the last quarter. Atwood & Palmer Inc. purchased a new position in shares of Humana during the third quarter worth about $29,000. Ashton Thomas Securities LLC acquired a new stake in shares of Humana during the third quarter worth about $31,000. Finally, Your Advocates Ltd. LLP lifted its holdings in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

HUM stock traded up $0.57 during trading on Wednesday, reaching $296.16. 59,608 shares of the company were exchanged, compared to its average volume of 1,864,491. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock’s 50 day moving average price is $276.28 and its 200 day moving average price is $330.23. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $526.47. The company has a market cap of $35.66 billion, a P/E ratio of 26.17, a PEG ratio of 2.40 and a beta of 0.52.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. As a group, analysts predict that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.20%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio is currently 31.36%.

Wall Street Analysts Forecast Growth

HUM has been the topic of several research analyst reports. Jefferies Financial Group lowered Humana from a “buy” rating to a “hold” rating and cut their price target for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a report on Tuesday, October 8th. Barclays increased their price target on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Stephens restated an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a research note on Wednesday, October 9th. Finally, Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.